How Far-UVC and Next-Gen Ventilation Are Giving Buildings 'Immune Systems'

For decades, the water we drink has been rigorously filtered and treated to prevent disease, yet the air we breathe indoors has remained largely unmanaged. Following the devastating lessons of the COVID-19 pandemic, the federal government is now investing $150 million into technologies designed to give buildings their own "immune systems." The goal is to actively neutralize airborne pathogens in real-time, fundamentally shifting how commercial and public spaces protect their occupants.[1][4]

Historically, indoor air quality standards were designed primarily for comfort. For over a century, building codes focused on regulating temperature, controlling humidity, and diluting noticeable odors. While hospitals and specialized laboratories utilized advanced infection-control ventilation, the vast majority of offices, schools, and retail spaces relied on minimal outdoor air exchange rates that were halved in the 1980s to save energy. The result was a built environment highly susceptible to the rapid spread of respiratory viruses.[2][4]

That paradigm is now undergoing a radical transformation. The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) recently introduced Standard 241, officially titled "Control of Infectious Aerosols." Developed in an unprecedented 116 days at the urging of the White House, the standard represents the first comprehensive, code-enforceable framework designed specifically to mitigate the risk of airborne disease transmission in everyday buildings.[2]

The cornerstone of Standard 241 is a shift from prescriptive rules to a performance-based metric known as the Equivalent Clean Airflow Rate (ECAi). Rather than simply dictating how much outside air a building must pump inside—a process that is incredibly energy-intensive due to the need to heat or cool that air—the new standard allows building operators to meet clean-air targets through a combination of ventilation, high-efficiency filtration, and active air-cleaning technologies.[2][4]

This technology-agnostic approach has accelerated the deployment of active disinfection systems, most notably Far-UVC light. Traditional germicidal ultraviolet light (UV-C) operates at a wavelength of 254 nanometers. While highly effective at destroying the DNA and RNA of viruses and bacteria, 254 nm light penetrates the upper layers of human skin and eyes, causing cataracts and skin cancer. Consequently, traditional UV-C can only be used safely inside enclosed HVAC ducts or in unoccupied rooms.[3][4]

Far-UVC, however, operates at a shorter wavelength of 222 nanometers. This specific wavelength possesses a unique biophysical property: it is strongly absorbed by biological materials, meaning it cannot penetrate the stratum corneum—the microscopic outer layer of dead human skin cells—nor the tear layer of the eye. To human occupants, the light is entirely harmless.[3]

Yet, because viruses and bacteria are physically smaller than the depth of a human cell, Far-UVC light easily penetrates these microscopic pathogens. When exposed to 222 nm light, the genetic material of aerosolized viruses is rapidly destroyed through photohydration and photo-cross-linking, inhibiting their ability to replicate and cause infection.[3]

The efficacy of this technology in real-world applications is striking. Studies have demonstrated that continuous, low-dose Far-UVC exposure can inactivate approximately 98% of aerosolized pathogens within a room in a matter of minutes. Unlike traditional air purifiers that require contaminated air to be pulled across a room and through a filter, Far-UVC provides whole-room direct exposure. It actively neutralizes the "breath plume" between individuals engaged in conversation, effectively intercepting the virus before it can cross the physical space between a host and a new target.[4]

Beyond infectious diseases, researchers are discovering that building immune systems may also alleviate chronic respiratory conditions. Recent studies indicate that Far-UVC exposure alters the molecular structure of airborne allergen proteins, including those from dust mites, pet dander, and mold.

When these allergen proteins undergo photooxidation from the 222 nm light, their physical shape changes. The human immune system relies on precise structural recognition—like a lock and key—to trigger an allergic response. Because the Far-UVC light warps the "key," the immune system no longer recognizes the allergen as effectively. In controlled environments, 30 minutes of Far-UVC exposure reduced the immune-based detection of airborne allergens by 20 to 25%.

Despite these immense benefits, the widespread deployment of whole-room Far-UVC is not without scientific hurdles. The most heavily debated issue among indoor air chemists is the technology's impact on secondary air chemistry.

Far-UVC light interacts with oxygen to produce low levels of ozone. While the ozone generated is typically below regulatory safety thresholds, it can react with volatile organic compounds (VOCs)—chemicals emitted by cleaning supplies, furniture, and building materials—to create ultrafine particulate matter. Balancing the undeniable benefits of rapid pathogen inactivation against the potential long-term respiratory effects of these chemical byproducts remains a critical area of ongoing research.[3][4]

To navigate these complexities, ASHRAE Standard 241 introduces the concept of an "Infection Risk Management Mode" (IRMM). Buildings are not expected to run their immune systems at maximum capacity at all times. Instead, facilities will operate under standard energy-efficient ventilation during periods of low risk.[2]

When public health authorities declare a high-risk period—such as a severe seasonal influenza outbreak or the emergence of a novel pandemic strain—building operators can toggle the IRMM. This activates the Far-UVC fixtures, maximizes HEPA filtration, and increases equivalent clean airflow to the stringent targets required to suppress disease transmission.[2][4]

The integration of these technologies represents a monumental leap in public health infrastructure. Just as the 19th-century cholera epidemics spurred the creation of modern municipal water treatment, the recent pandemic is forcing a permanent evolution in how we engineer the air we share. By treating indoor air as a manageable vector rather than an inevitable hazard, the buildings of the future will actively protect the people inside them.[1][4]